Abstract
The purpose of this review is to update knowledge on therapy-related myeloid neoplasms (t-MN), taking into account the new 2008 WHO classification, new genome-wide approaches for the definition of susceptibility towards t-MN and the introduction of new more aggressive treatments in cancer patients.
Lingua originale | English |
---|---|
pagine (da-a) | 672-680 |
Numero di pagine | 9 |
Rivista | Current Opinion in Oncology |
Volume | 23 |
DOI | |
Stato di pubblicazione | Pubblicato - 2011 |
Pubblicato esternamente | Sì |
Keywords
- Humans
- Leukemia, Myeloid, Acute
- Neoplasms, Second Primary